Unlicensed and off label prescribing of drugs in general practice

被引:151
|
作者
McIntyre, J
Conroy, S
Avery, A
Corns, H
Choonara, I
机构
[1] Univ Nottingham, Derbyshire Childrens Hosp, Acad Div Child Hlth, Derby DE22 3NE, England
[2] Univ Nottingham Hosp, Sch Community Hlth Sci, Div Gen Practice, Nottingham NG7 2UH, England
关键词
unlicensed prescribing; off label prescribing; drugs; general practice;
D O I
10.1136/adc.83.6.498
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim-To determine the incidence and nature of unlicensed and off label prescribing of drugs for children in general practice. Methods-A retrospective analysis of all prescriptions for one year involving children (aged 12 years or under) from a single suburban general practice in the English Midlands. Prescribed drugs were categorised as licensed, unlicensed (without a product licence), or used in an off label way (outside the terms of their product licence). Results-During 1997 there were 3347 prescription items involving 1175 children and 160 different drugs. A total of 2828 (84.5%) prescriptions were for licensed medicines used in a licensed way; 10 (0.3%) were for unlicensed medicines; and 351 (10.5%) were licensed medicines used in an off label way. For 158 (4.7%) the information was insufficient to determine licence status. Conclusion-This is the first study to show that a significant number of drugs prescribed for children by general practitioners are off label and highlights the anomalies and inadequacies of drug information for prescribers.
引用
收藏
页码:498 / 501
页数:4
相关论文
共 50 条
  • [21] Clinical Setting Influences Off-Label and Unlicensed Prescribing in a Paediatric Teaching Hospital
    Czarniak, Petra
    Bint, Lewis
    Favie, Laurent
    Parsons, Richard
    Hughes, Jeff
    Sunderland, Bruce
    PLOS ONE, 2015, 10 (03):
  • [22] Exploratory Findings of Prescribing Unlicensed and Off-Label Medicines Among Children and Neonates
    Shakeel, Sadia
    Iffat, Wajiha
    Nesar, Shagufta
    Zaidi, Hina
    Jamshed, Shazia
    INTEGRATED PHARMACY RESEARCH AND PRACTICE, 2020, 9 : 33 - 39
  • [23] Off-label and unlicensed prescribing for children: have we made any progress?
    Waller, D. G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (01) : 1 - 2
  • [24] Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
    Muhammad Aamir
    Jamshaid Ali Khan
    Faisal Shakeel
    Rabeea Shareef
    Nazia Shah
    BMC Pediatrics, 18
  • [25] Off-Label and Unlicensed Prescribing of Medicines in Paediatric Populations: Occurrence and Safety Aspects
    Aagaard, Lise
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (04) : 215 - 218
  • [26] Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability
    Aagaard, Lise
    Kristensen, Kent
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 509 - 512
  • [27] Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
    Aamir, Muhammad
    Khan, Jamshaid Ali
    Shakeel, Faisal
    Shareef, Rabeea
    Shah, Nazia
    BMC PEDIATRICS, 2018, 18
  • [28] LITIGATION AND PRESCRIBING DRUGS FOR UNLICENSED INDICATIONS
    FISK, NM
    SHENNAN, AH
    LANCET, 1993, 341 (8854): : 1218 - 1218
  • [29] Off-label prescribing: best practice or malpractice?
    Stahl, Stephen M.
    CNS SPECTRUMS, 2013, 18 (01) : 1 - 4
  • [30] Unlicensed and off label prescription of drugs to children: population based cohort study
    't Jong, GW
    Eland, IA
    Sturkenboom, MCJM
    van den Anker, JN
    Stricker, BHC
    BRITISH MEDICAL JOURNAL, 2002, 324 (7349): : 1313 - 1314